| HOME >> BIOLOGY >> TECHNOLOGY |
and $453 for the six months
ended June 30, 2007) 7,449 6,976 14,767 14,608
Products 1,840 1,881 3,832 3,829
General, administrative,
and marketing 12,358 10,842 24,425 23,177
Research and development 1,307 978 2,752 2,036
Interest expense 69 187 139 340
Interest income (71) (105) (193) (202)
Change in valuation of
derivative -- 866 -- 821
Other expense (income), net 55 13 (27) 102
Total costs and expenses 23,007 21,638 45,695 44,711
Income before income taxes 4,148 1,373 7,028 2,824
Income tax expense 260 82 375 179
Net income $3,888 $1,291 $6,653 $2,645
Effect of preferred stock
dividends -- -- -- (243)
Net income applicable to
common shares $3,888 $1,291 $6,653 $2,402
Income per common share:
Basic $0.14 $ 0.05 $0.24 $0.10
Diluted $0.14 $0.05 $0.24 $0.09
Weighted average common
shares outstanding:
Basic 27,756 25,480 27,661 25,234
Diluted 28,381 26,333 28,211 25,969
CRYOLIFE, INC. AND SUBSIDIARIES
Financial Highlights
(In thousands)
Three Months Ended Six Months Ended
June 30, June 30,
'/>"/>
| SOURCE CryoLife, Inc. Copyright©2008 PR Newswire. All rights reserved |